Immunology and Microbiology
Serotype
100%
Mesenchymal Stem Cell
84%
Immunology
72%
Tonsil
46%
Immunogenicity
41%
Pneumococcal Vaccine
41%
Pneumococcus
40%
CD34
37%
Immune Response
30%
Titer
28%
Adolescence
27%
Haemophilus Influenzae Type B
26%
Antibody Response
17%
Immunoglobulin G
16%
Hematopoietic Cell
16%
Measles
15%
Palatine Tonsil
15%
Cytokine
14%
Intravenous Immunoglobulin
14%
Streptococcus Pneumonia
14%
Conjugate Vaccine
14%
Seroprevalence
14%
ELISA
13%
Pneumococcal Polysaccharide Vaccine
12%
Umbilical Cord Blood
12%
Thrombopoietin
12%
Immunity
11%
Enzyme-Linked Immunosorbent Assay
11%
Rubella
11%
Graft-Versus-Host Disease
11%
Kawasaki Disease
11%
Adipose Tissue
10%
Maturation
10%
Chemokine
10%
Neisseria meningitidis
10%
Human Respiratory Syncytial Virus
10%
Mouse Model
9%
Hepatitis A Virus
9%
Prevalence
9%
Normal Human
9%
Infectious Agent
9%
Infectious Disease
9%
Engraftment
8%
Lower Respiratory Tract
8%
Immunoglobulin G Antibody
8%
Bone Marrow Cell
8%
Body Mass
8%
Lineages
8%
Monoclonal Antibody
8%
Coculture
7%
T Cell
7%
Birth Weight
7%
Hib Vaccine
7%
Opsonin
7%
Follicular Dendritic Cells
6%
Rotavirus
6%
Haemophilus influenzae
6%
Polyploidy
6%
Cross-Reactivity
6%
Blood Pressure
6%
Oxidative Stress
6%
Urinary Tract
6%
B Cell
6%
Diphtheria Toxoid CRM197
6%
Stem Cell Factor
6%
Cell Culture
6%
Japanese Encephalitis Vaccine
6%
Lactobacillus
6%
Intestine Flora
6%
Osteoclast
6%
Hemophagocytic Lymphohistiocytosis
6%
Chickenpox
6%
Respiratory Burst
6%
Antibiotic Sensitivity
6%
Phagocytosis
5%
C-Reactive Protein
5%
Gene Expression
5%
Granulocyte Colony-Stimulating Factor
5%
Cell Transplantation
5%
Otitis Media
5%
Blood Plasma
5%
Immunoglobulin M
5%
Overall Survival
5%
Leporidae
5%
Wart Virus
5%
Antibody Blood Level
5%
Child Growth
5%
Colony Forming Unit S
5%
Streptococcus Agalactiae
5%
Drug Megadose
5%
Liver Tissue
5%
White Matter
5%
Virus Antibody
5%
Lymph Node
5%
RANKL
5%
Antibodies
5%
Medicine and Dentistry
Mesenchymal Stem Cell
84%
Tonsil
67%
Adolescence
61%
Serotype
29%
Disease
27%
In Vitro
24%
Very Low Birth Weight
22%
Pregnancy
20%
Pneumococcus Vaccine
19%
Birth Weight
19%
Kawasaki Disease
19%
Cord Blood
17%
Body Mass Index
17%
Prevalence
16%
Immunogenicity
16%
Infection
16%
Prematurity
15%
Metabolic Syndrome
14%
Hemophagocytic Syndrome
14%
Programmed Cell Death
13%
Oxidative Stress
13%
Wart Virus
12%
Palatine Tonsil
12%
Premature Labor
12%
Stem Cell
12%
Endothelial Cell
12%
Blood Pressure
12%
Arsenic Trioxide
11%
Wart Virus Vaccine
11%
Urinary Tract Infection
10%
Ganglioneuroblastoma
10%
Lung Dysplasia
10%
Pneumococcus
10%
Obesity
10%
Bone Marrow Cell
10%
Ex Vivo
9%
Cohort Analysis
9%
Clinical Feature
9%
Quality Improvement
9%
Systolic Blood Pressure
8%
Cohort Effect
8%
Hematopoietic Cell
8%
Engraftment
8%
Immunity
8%
Antibody Response
8%
High Density Lipoprotein Cholesterol
8%
Survival Rate
8%
Human Papillomavirus Type 6
8%
Neuroblastoma Cell Line
7%
Liver Fibrosis
7%
Sex Difference
7%
Neisseria meningitidis
7%
Drug Therapy
7%
Sepsis
7%
Antioxidant
7%
Particular Matter 2.5
7%
Pediatrics Patient
7%
Immune Response
7%
Insulin Resistance
7%
Echocardiography
7%
Triacylglycerol
7%
C Reactive Protein
7%
Ascorbic Acid
7%
Thrombopoietin
7%
SH-SY5Y
7%
Cytokine
7%
Skeletal Muscle
7%
Logistic Regression Analysis
7%
Immunization
6%
Follicular Dendritic Cells
6%
Cerebral Hemorrhage
6%
Histiocytosis
6%
Neuroblastoma Cell
6%
Pediatric Hematology
6%
Tretinoin
6%
Gestational Age
6%
Hepatocyte
6%
Ductus Arteriosus
6%
Vitamin D
6%
Angiogenesis Inhibitor
6%
Diamond-Blackfan Anemia
6%
Acute Otitis Media
6%
Low Density Lipoprotein Cholesterol
6%
Interleukin 8 Receptor, Beta
6%
Bisphenol A
6%
Preschooler
6%
Japanese Encephalitis Vaccine
6%
Pneumococcal Infection
6%
Overall Survival
6%
Toddlers
6%
Acute Pyelonephritis
6%
Infusion
6%
Health Care Cost
5%
Adverse Event
5%
Cardiovascular Risk
5%
Retrospective Study
5%
Odds Ratio
5%
Exon
5%
Low Birth Weight
5%
Neutrophil
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
37%
Infection
24%
Pneumococcus Vaccine
22%
Adverse Event
20%
Prevalence
20%
Urinary Tract Infection
16%
Mucocutaneous Lymph Node Syndrome
15%
Enzyme-Linked Immunosorbent Assay
14%
Haemophilus influenzae
13%
Human Papillomavirus
12%
Conjugate Vaccine
11%
Haemophilus Influenzae Type B
11%
Promyelocytic Leukemia
11%
Wart Virus Vaccine
11%
Cohort Study
11%
Seroprevalence
10%
Streptococcus
9%
Streptococcus Agalactiae
9%
Japanese Encephalitis Vaccine
9%
Metabolic Syndrome X
9%
Very Low Birth Weight
9%
Probiotic Agent
9%
Measles
9%
Staphylococcus Aureus
9%
Hepatitis A Vaccine
9%
Human Respiratory Syncytial Virus
9%
Pneumococcal Infection
8%
Infectious Agent
8%
Insulin Resistance
8%
Low Birth Weight
8%
Human Papillomavirus Type 6
8%
Bacterial Infection
8%
Rubella
8%
Mumps
8%
Obesity
8%
Chickenpox
8%
Escherichia coli
8%
Bacterial Meningitis
7%
Lower Respiratory Tract Infection
7%
Tumor Necrosis Factor
7%
Pertussis
7%
Sepsis
7%
Vesicoureteral Reflux
7%
Elevated Blood Pressure
7%
Immunoglobulin
7%
Haemophilus Influenzae Type B Vaccine
7%
Acute Pyelonephritis
6%
Polysaccharide
6%
Hepatitis A
6%
Lactobacillus
6%
Premature Labor
6%
Seroepidemiology
6%
Cell Culture
6%
Androgen
6%
Blackfan Diamond Anemia
6%
Polyethylene Glycol
6%
Inflammation
5%
Subcutaneous Injection
5%
Retrospective Study
5%
Meningitis
5%
Hand Foot and Mouth Disease
5%
Monocrotaline
5%
Cardiovascular Disease
5%
Liver Injury
5%
Enterovirus A71
5%
Monoclonal Antibody
5%